icon_folder.gif   Conference Reports for NATAP  
Back grey_arrow_rt.gif
 
 
 
Hepatitis Updates:
Lamivudine Durability in HBV Treatment; Racial Differences Regarding HCV, Iron Stores &Response to HCV Therapy; Threshold for Neutropenia in Interferon Therapy; ALT in Predicting Liver Fibrosis; RNA Interference in Discovering Drugs for HBV.